Trial Profile
A Phase II Single Arm Study to Evaluate the Safety and Efficacy of RAD001 as Monotherapy in Treatment naive Advanced Cholangiocarcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 07 Feb 2012 New trial record